Elyse Wolf
Family Medicine · Geneseo, ILNPI 1629738661
Payments from drug & device makers
Across 205 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$729
- Pfizer$417
- AbbVie$409
- Novartis$334
- Novo Nordisk$272
- Exact Sciences$261
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,76998%
- Education$852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 40 | $729 |
| Pfizer | 27 | $417 |
| AbbVie | 16 | $409 |
| Novartis | 18 | $334 |
| Novo Nordisk | 13 | $272 |
| Exact Sciences | 16 | $261 |
| Lilly USA, LLC | 11 | $165 |
| Eisai Inc. | 7 | $162 |
| Astellas Pharma US Inc | 3 | $120 |
| Organon | 5 | $106 |
| Amgen | 5 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $87 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $82 |
| Ironshore Pharmaceuticals Inc. | 4 | $74 |
| Bayer | 5 | $72 |
| Lundbeck LLC | 4 | $72 |
| Phathom Pharmaceuticals, Inc. | 6 | $70 |
| Boehringer Ingelheim | 3 | $57 |
| Idorsia Pharmaceuticals US Inc | 3 | $50 |
| Dexcom, Inc. | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $36 |
| Ceribell, Inc. | 1 | $34 |
| Almatica Pharma LLC | 2 | $31 |
| Baudax Bio Inc. | 1 | $25 |
| Insulet Corporation | 1 | $17 |
| Shield Therapeutics Inc | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QULIPTA$117
How this compares
$3,854 in reported general payments places this provider in the 85th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 68 | $75,526 |
| EliquisApixaban | 100 | $72,229 |
| TrulicityDulaglutide | 46 | $45,863 |
| FarxigaDapagliflozin Propanediol | 47 | $36,520 |
| JardianceEmpagliflozin | 36 | $36,053 |
| OzempicSemaglutide | 25 | $34,491 |
| MyrbetriqMirabegron | 60 | $23,800 |
| JanuviaSitagliptin Phosphate | 17 | $19,205 |
| TrintellixVortioxetine Hydrobromide | 39 | $12,522 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 16 | $10,489 |
| Breo ElliptaFluticasone/Vilanterol | 25 | $9,967 |
| XareltoRivaroxaban | 25 | $8,565 |
| Spiriva HandihalerTiotropium Bromide | 12 | $5,955 |
| CreonLipase/Protease/Amylase | 13 | $4,894 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 108 | $3,016 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $165 | $121,388114 claims |
| PfizerEliquis | $417 | $72,229100 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $729 | $47,00963 claims |
| Boehringer IngelheimJardiance | $57 | $36,05336 claims |
| Novo NordiskOzempic | $272 | $34,49125 claims |
| Astellas Pharma US IncMyrbetriq | $120 | $23,80060 claims |
| AbbVieCreon, Synthroid | $409 | $6,06733 claims |
| Almatica Pharma LLCSertraline Hcl | $31 | $72467 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Geneseo
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
- Mark ChristensenNew Lenox$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.